Role of DNA methylation in cardiovascular diseases

Clinical and Experimental Hypertension

Volumn 38, Issue 3, 2016, Pages 261-267

  Zhang, Ye ^a,b   Zeng, Chunyu ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Institute of Cardiology   (China)

Author keywords

Cardiovascular diseases; DNA methylation; Environmental factor; Epigenetic; Gene

Indexed keywords

AGING; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIABETES MELLITUS; DNA METHYLATION; GENDER; GENETIC TRANSCRIPTION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; NONHUMAN; PATHOGENESIS; PATHOLOGY; SMOKING; GENETIC EPIGENESIS; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; PATHOPHYSIOLOGY; PHENOTYPE;

CARDIOVASCULAR DISEASES; DNA METHYLATION; EPIGENESIS, GENETIC; GENE-ENVIRONMENT INTERACTION; HUMANS; PHENOTYPE;

EID: 84961962703     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2015.1107087     Document Type: Article

References (73)

1. Bird A. Perceptions of epigenetics. Nature 2007;447(7143): 396-8.
2. Feinberg AP, Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun 1983;111 (1): 47-54.
3. Gusterson RJ, Jazrawi E, Adcock IM, Latchman DS. The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity. J Biol Chem 2003;278 (9): 6838-47.
4. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005;102(30): 10604-9.
5. Hiltunen MO, Turunen MP, Häkkinen TP, et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 2002;7(1): 5-11.
6. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010;28(10): 1057-68.
7. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010;28(10): 1057-68.
8. Handy DE, Castro R, Loscalzo J. Epigenetic modifications: Basic mechanisms and role in cardiovascular disease. Circulation 2011;123(19): 2145-56.
9. Baccarelli A, Rienstra M, Benjamin EJ. Cardiovascular epigenetics: Basic concepts and results from animal and human studies. Circ Cardiovasc Genet 2010;3(6): 567-73.
10. Ordovás JM, Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol 2010;7(9): 510-19.
11. Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol 1987;196(2): 261-82.
12. Weber M, Hellmann I, Stadler MB, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007;39(4): 457-66.
13. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999;99(3): 247-57.
14. Jurkowska RZ, Jurkowski TP, Jeltsch A. Structure and function of mammalian DNA methyltransferases. Chembiochem 2011;12 (2): 206-22.
15. Bogdanovic O, Veenstra GJ. DNA methylation and methyl-CpG binding proteins: Developmental requirements and function. Chromosoma 2009;118(5): 549-65.
16. Daniel FI, Cherubini K, Yurgel LS, et al. The role of epigenetic transcription repression and DNA methyltransferases in cancer. Cancer 2011;117(4): 677-87.
17. Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 2005;24(48): 7213-23.
18. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis 2010;31(1): 27-36.
19. Wilson VL, Jones PA. DNA methylation decreases in aging but not in immortal cells. Science 1983;220(4601): 1055-7.
20. Thompson RF, Atzmon G, Gheorghe C, et al. Tissue-specific dysregulation of DNA methylation in aging. Aging Cell 2010;9 (4): 506-18.
21. Bollati V, Schwartz J, Wright R, et al. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev 2009;130(4): 234-9.
22. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 1999;43(4): 985-91.
23. Issa JP, Vertino PM, Boehm CD, et al. Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis. Proc Natl Acad Sci U S A 1996;93(21): 11757-62.
24. Bornman DM, Mathew S, Alsruhe J, et al. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 2001;159 (3): 831-5.
25. Liu C, Xu D, Sjöberg J, et al. Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp Cell Res 2004;297(1): 61-7.
26. Choi EK, Uyeno S, Nishida N, et al. Alterations of c-fos gene methylation in the processes of aging and tumorigenesis in human liver. Mutat Res 1996;354(1): 123-8.
27. Takatsu M, Uyeno S, Komura J, et al. Age-dependent alterations in mRNA level and promoter methylation of collagen alpha1(I) gene in human periodontal ligament. Mech Ageing Dev 1999;110 (1-2): 37-48.
28. So K, Tamura G, Honda T, et al. Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci 2006;97(11): 1155-8.
29. Bjornsson HT, Sigurdsson MI, Fallin MD, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA 2008;299(24): 2877-83.
30. Calvanese V, Lara E, Kahn A, Fraga MF. The role of epigenetics in aging and age-related diseases. Ageing Res Rev 2009;8(4): 268-76.
31. Labosky PA, Barlow DP, Hogan BL. Mouse embryonic germ (EG) cell lines: Transmission through the germline and differences in the methylation imprint of insulin-like growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines. Development 1994;120(11): 3197-204.
32. Tada T, Tada M, Hilton K, et al. Epigenotype switching of imprintable loci in embryonic germ cells. Dev Genes Evol 1998;207(8): 551-61.
33. Durcova-Hills G, Burgoyne P, McLaren A. Analysis of sex differences in EGC imprinting. Dev Biol 2004;268(1): 105-10.
34. Gebert C, Wrenzycki C, Herrmann D, et al. DNA methylation in the IGF2 intragenic DMR is re-established in a sex-specific manner in bovine blastocysts after somatic cloning. Genomics 2009;94 (1): 63-9.
35. El-Maarri O, Becker T, Junen J, et al. Gender-specific differences in levels of DNA methylation at selected loci from human total blood: A tendency toward higher methylation levels in males. Hum Genet 2007;122(5): 505-14.
36. Bermejo-Alvarez P, Rizos D, Rath D, et al. Epigenetic differences between male and female bovine blastocysts produced in vitro. Physiol Genomics 2008;32(2): 264-72.
37. Kim M, Long TI, Arakawa K, et al. DNA methylation as a biomarker for cardiovascular disease risk. PLoS One 2010;5(3): E9692.
38. Active and passive tobacco exposure: A serious pediatric health problem. A statement from the Committee on Atherosclerosis and Hypertension in Children, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994;90 (5): 2581-90.
39. Breton CV, Byun HM, Wenten M, et al. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med 2009;180(5): 462-7.
40. Terry MB, Ferris JS, Pilsner R, et al. Genomic DNA methylation among women in a multiethnic New York City birth cohort. Cancer Epidemiol Biomarkers Prev 2008;17(9): 2306-10.
41. Pulling LC, Vuillemenot BR, Hutt JA, et al. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res 2004;64(11): 3844-8.
42. Launay JM, Del Pino M, Chironi G, et al. Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulation. PLoS One 2009;4(11): E7959.
43. Lund G, Andersson L, Lauria M, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 2004;279 (28): 29147-54.
44. Mitra S, Khaidakov M, Lu J, et al. Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation. Am J Physiol Heart Circ Physiol 2011;301(2): H506-13.
45. Chen KC, Wang YS, Hu CY, et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications ofMMP-2/MMP-9 genes: A novel mechanism for cardiovascular diseases. FASEB J 2011;25(5): 1718-28.
46. Panin LE, Polyakov LM, Kolosova NG, et al. Distribution of tocopherol and apolipoprotein A-I immunoreactivity in rat liver chromatin. Membr Cell Biol 1998;11(5): 631-40.
47. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 2002;288(16): 2015-22.
48. Yideng J, Jianzhong Z, Ying H, et al. Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol 2007;26(8): 603-11.
49. Jamaluddin MD, Chen I, Yang F, et al. Homocysteine inhibits endothelial cell growth via DNA hypomethylation of the cyclin A gene. Blood 2007;110(10): 3648-55.
50. Yi-Deng J, Tao S, Hui-Ping Z, et al. Folate and ApoE DNA methylation induced by homocysteine in human monocytes. DNA Cell Biol 2007;26(10): 737-44.
51. Yideng J, Zhihong L, Jiantuan X, et al. Homocysteinemediated PPARalpha, gamma DNA methylation and its potential pathogenic mechanism in monocytes. DNA Cell Biol 2008;27(3): 143-50.
52. Chang PY, Lu SC, Lee CM, et al. Homocysteine inhibits arterial endothelial cell growth through transcriptional downregulation of fibroblast growth factor-2 involving G protein and DNA methylation. Circ Res 2008;102(8): 933-41.
53. Liu C, Wang Q, Guo H, et al. Plasma S-adenosylhomocysteine is a better biomarker of atherosclerosis than homocysteine in apolipoprotein E-deficient mice fed high dietary methionine. J Nutr 2008;138(2): 311-5.
54. Antoniades C, Shirodaria C, Leeson P, et al. MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis. Circulation 2009;119(18): 2507-15.
55. Lai CQ, Parnell LD, Troen AM, et al. MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma Vitamin B-6 and folate. Am J Clin Nutr 2010;91(5): 1377-86.
56. Kuroda A, Rauch TA, Todorov I, et al. Insulin gene expression is regulated by DNA methylation. PLoS One 2009;4(9): E6953.
57. Morgan HD, Sutherland HG, Martin DI, Whitelaw E. Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 1999;23 (3): 314-8.
58. Ling C, Del Guerra S, Lupi R, et al. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 2008;51(4): 615-22.
59. Smolarek I, Wyszko E, Barciszewska AM, et al. Global DNA methylation changes in blood of patients with essential hypertension. Med Sci Monit 2010;16(3): CR149-155.
60. Rivière G, Lienhard D, Andrieu T, et al. Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics 2011;6(4): 478-89.
61. Alikhani-Koopaei R, Fouladkou F, Frey FJ, Frey BM. Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression. J Clin Invest 2004;114(8): 1146-57.
62. Friso S, Pizzolo F, Choi SW, et al. Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. Atherosclerosis 2008;199(2): 323-7.
63. Lee HA, Baek I, Seok YM, et al. Promoter hypomethylation upregulates Na+-K+-2Cl-cotransporter 1 in spontaneously hypertensive rats. Biochem Biophys Res Commun 2010;396(2): 252-7.
64. Laukkanen MO, Mannermaa S, Hiltunen MO, et al. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol 1999;19(9): 2171-8.
65. Castro R, Rivera I, Struys EA, et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem 2003;49(8): 1292-6.
66. Stenvinkel P, Karimi M, Johansson S, et al. Impact of inflammation on epigenetic DNA methylation-A novel risk factor for cardiovascular disease? J Intern Med 2007;261(5): 488-99.
67. Weissberg PL, Bennett MR. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340(24): 1928-9.
68. Wilson AG. Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol 2008;79(8 Suppl): 1514-19.
69. Armenante F, Merola M, Furia A, Palmieri M. Repression of the IL-6 gene is associated with hypermethylation. Biochem Biophys Res Commun 1999;258(3): 644-7.
70. Hodge DR, Xiao W, Clausen PA, et al. Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 2001;276(43): 39508-11.
71. Hodge DR, Peng B, Cherry JC, et al. Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res 2005;65(11): 4673-82.
72. Galm O, Yoshikawa H, Esteller M, et al. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma. Blood 2003;101(7): 2784-8.
73. Sato N, Maehara N, Su GH, Goggins M. Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness. J Natl Cancer Inst 2003;95(4): 327-30.